CompuMed, Inc. (CMPD)
OTCMKTS
· Delayed Price · Currency is USD
3.520
+0.520 (17.33%)
May 15, 2025, 9:32 AM EDT
CompuMed Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2002 - 2006 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '12 Mar 31, 2012 | Sep '11 Sep 30, 2011 | Sep '10 Sep 30, 2010 | Sep '09 Sep 30, 2009 | Sep '08 Sep 30, 2008 | Sep '07 Sep 30, 2007 | 2002 - 2006 |
| Revenue | 1.69 | 1.68 | 1.76 | 2.05 | 2.15 | 2.22 | Upgrade
|
| Revenue Growth (YoY) | 0.47% | -4.60% | -13.96% | -4.88% | -2.84% | 4.83% | Upgrade
|
| Cost of Revenue | 0.84 | 0.8 | 0.74 | 0.75 | 0.91 | 0.72 | Upgrade
|
| Gross Profit | 0.85 | 0.88 | 1.02 | 1.29 | 1.24 | 1.5 | Upgrade
|
| Selling, General & Admin | 0.9 | 1.08 | 1.24 | 1.3 | 2.06 | 2.08 | Upgrade
|
| Research & Development | - | - | 0.01 | 0.04 | 0.42 | 0.41 | Upgrade
|
| Operating Expenses | 0.98 | 1.18 | 1.37 | 1.5 | 2.59 | 2.57 | Upgrade
|
| Operating Income | -0.13 | -0.3 | -0.35 | -0.2 | -1.35 | -1.08 | Upgrade
|
| Interest Expense | -0.02 | -0.03 | -0.03 | -0.05 | -0.05 | -0.03 | Upgrade
|
| Interest & Investment Income | - | - | - | 0 | 0.03 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | 0.1 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.04 | -0.22 | -0.38 | -0.25 | -1.37 | -1.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.07 | -0.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0 | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.04 | - | Upgrade
|
| Pretax Income | -0.04 | -0.22 | -0.38 | -0.25 | -1.48 | -1.38 | Upgrade
|
| Net Income | -0.04 | -0.22 | -0.38 | -0.25 | -1.48 | -1.38 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.11 | 0.07 | 0.09 | - | - | - | Upgrade
|
| Net Income to Common | -0.15 | -0.3 | -0.47 | -0.25 | -1.48 | -1.38 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 1.66% | 2.27% | 3.54% | 2.00% | 3.31% | 3.70% | Upgrade
|
| EPS (Basic) | -0.13 | -0.27 | -0.44 | -0.24 | -1.46 | -1.40 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.27 | -0.44 | -0.24 | -1.46 | -1.40 | Upgrade
|
| Free Cash Flow | -0.01 | -0.04 | -0.16 | -0.08 | -1.03 | -0.63 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.15 | -0.07 | -1.01 | -0.64 | Upgrade
|
| Gross Margin | 50.24% | 52.29% | 58.12% | 63.18% | 57.73% | 67.60% | Upgrade
|
| Operating Margin | -7.73% | -17.96% | -19.75% | -9.86% | -62.56% | -48.56% | Upgrade
|
| Profit Margin | -8.62% | -17.55% | -26.50% | -12.35% | -68.65% | -62.27% | Upgrade
|
| Free Cash Flow Margin | -0.83% | -2.08% | -9.31% | -3.81% | -47.89% | -28.57% | Upgrade
|
| EBITDA | -0.05 | -0.2 | -0.22 | -0.05 | -1.24 | -0.99 | Upgrade
|
| EBITDA Margin | -2.66% | -11.66% | -12.66% | -2.54% | -57.50% | -44.72% | Upgrade
|
| D&A For EBITDA | 0.09 | 0.11 | 0.13 | 0.15 | 0.11 | 0.09 | Upgrade
|
| EBIT | -0.13 | -0.3 | -0.35 | -0.2 | -1.35 | -1.08 | Upgrade
|
| EBIT Margin | -7.73% | -17.96% | -19.75% | -9.86% | -62.56% | -48.56% | Upgrade
|
| Revenue as Reported | 1.69 | 1.68 | 1.76 | 2.05 | 2.15 | 2.22 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.